Low integrated DNA repair score and lung cancer risk

Cancer Prevention Research

Volumn 7, Issue 4, 2014, Pages 398-406

  Sevilya, Ziv ^a   Leitner Dagan, Yael ^a   Pinchev, Mila ^b   Kremer, Ran ^c   Elinger, Dalia ^a   Rennert, Hedy S ^b   Schechtman, Edna ^d   Freedman, Laurence S ^e   Rennert, Gad ^b   Paz Elizur, Tamar ^a   Livneh, Zvi ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c Department of General Thoracic Surgery Rambam Health Care Campus ^*  (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

8 OXOGUANINE DNA GLYCOSYLASE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE 1; DNA GLYCOSYLTRANSFERASE; METHYLPURINE DNA GLYCOSYLASE; UNCLASSIFIED DRUG; APEX1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MPEG1 PROTEIN, HUMAN; OXOGUANINE GLYCOSYLASE 1, HUMAN; TUMOR MARKER;

AGED; ARTICLE; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EARLY DIAGNOSIS; ENZYME ACTIVITY; EXCISION REPAIR; FEMALE; HUMAN; HUMAN TISSUE; INTEGRATED DNA REPAIR SCORE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FOLLOW UP; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898893028     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0318     Document Type: Article

References (44)

1. Ford ES, Ajani UA, Croft JB, Crichley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98. (Pubitemid 46883773)
2. O'Callaghan T. Introduction: the prevention agenda. Nature 2011;471: S2-4.
3. Brower V. Biomarkers: portents of malignancy. Nature 2011;471: S19-21.
4. Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellenberger T. DNA repair and mutagenesis. 2nd ed. Washington DC: ASM Press; 2006.
5. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009;361:2449-60.
6. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-74. (Pubitemid 32467046)
7. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature Med. 2004;10:789-99. (Pubitemid 39070849)
8. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646 -74.
9. Nathanson KL, Domchek SM. Therapeutic approaches for women predisposed to breast cancer. Annu Rev Med 2011;62:295-306.
10. Wu X, Gu J, Spitz MR. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res 2007;67:3493-5. (Pubitemid 46762125)
11. Wei Q, Cheng L, Amos CI, Wang L-E, Guo Z, Hong WK, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92: 1764-72.
12. Kennedy DO, Agrawal M, Shen J, Terry MB, Zhang FF, Senie RT, et al. DNA repair capacity of lymphoblastoid cell lines derived from sisters discordant for breast cancer. J Natl Cancer Inst 2005;97: 127-32. (Pubitemid 40277092)
13. Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schechtman E, Livneh Z. Reduced DNA repair activity for oxidative damage and the risk of lung cancer. J Natl Cancer Inst 2003;95:1312-9. (Pubitemid 37160864)
14. Paz-Elizur T, Brenner DE, Livneh Z. Interrogating DNA repair in cancer risk assessment. Cancer Epidemiol Biomarkers Prev 2005; 14:1585-7. (Pubitemid 40995065)
15. Paz-Elizur T, Ben-Yosef R, Elinger D, Vexler A, Krupsky M, Berrebi A, et al. Reduced repair of the oxidative 8-oxoguanine DNA damage and the risk of head and neck cancer. Cancer Res 2006;66:11683-9. (Pubitemid 46094180)
16. Paz-Elizur T, Elinger D, Leitner-Dagan Y, Blumenstein S, Krupsky M, Berrebi A, et al. Development of an enzymatic DNA repair assay for molecular epidemiology studies: Distribution of OGG activity in healthy individuals. DNA Repair 2007;6:45-60. (Pubitemid 46014544)
17. Paz-Elizur T, Sevilya Z, Leitner-Dagan Y, Elinger D, Roisman LC, Livneh Z. DNA repair of oxidative damage in human carcinogenesis: potential application for cancer risk assessment and prevention. Cancer Lett 2008;266:60-72.
18. Leitner-Dagan Y, Sevilya Z, Pinchev M, Kramer R, Elinger D, Roisman LC, et al. N-methylpurine DNA glycosylase and OGG1 DNA repair activities: opposite associations with lung cancer risk. J Natl Cancer Inst 2012;104:1765-9.
19. Gackowski D, Speina E, Zielinska M, Kowalewski J, Rozalski R, Siomek A, et al. Products of oxidative DNA damage and repair as possible biomarkers of susceptibility to lung cancer. Cancer Res 2003;63: 4899- 902.
20. Speina E, Zielinska M, Barbin A, Gackowski D, Kowalewski J, Graziewicz MA, et al. Decreased repair activities of 1,N(6)-ethenoadenine and 3,N(4)-ethenocytosine in lung adenocarcinoma patients. Cancer Res 2003;63:4351-7. (Pubitemid 36951003)
21. Crosbie PA, Watson AJ, Agius R, Barber PV, Margison GP, Povey AC. Elevated N3-methylpurine-DNA glycosylase DNA repair activity is associated with lung cancer. Mutat Res 2012;732:43-6.
22. Stavridis JC. Oxidation: the cornerstone of carcinogenesis: oxidation and tobacco smoke carcinogenesis.Arelationship between cause and effect. Springer Science + Business Media B.V.; 2010.
23. Coquerelle T, Dosch J, Kaina B. Overexpression of N-methylpurine-DNA glycosylase in Chinese hamster ovary cells renders them more sensitive to the production of chromosomal aberrations by methylating agents-a case of imbalanced DNA repair. Mutat Res 1995;336:9-17.
24. Glassner BJ, Rasmussen LJ, Najarian MT, Posnick LM, Samson LD. Generation of a strong mutator phenotype in yeast by imbalanced base excision repair. Proc Natl Acad Sci U S A 1998;95:9997-10002. (Pubitemid 28415283)
25. Hofseth LJ, Khan MA, Ambrose M, Nikolayeva O, Xu-Welliver M, Kartalou M, et al. The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation. J Clin Invest. 2003;112:1887-94. (Pubitemid 38063712)
26. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993;362:709-15. (Pubitemid 23125973)
27. Sung JS, Demple B. Roles of base excision repair subpathways in correcting oxidized abasic sites in DNA. FEBS J. 2006;273:1620-9. (Pubitemid 43779816)
28. Krokan HE, Standal R, Slupphaug G. DNA glycosylases in the base excision repair of DNA. Biochem J 1997;325:1-16. (Pubitemid 27322679)
29. Meira LB, Burgis NE, Samson LD. Base excision repair. Adv Exp Med Biol 2005;570:125-73. (Pubitemid 47413188)
30. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
31. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-71. (Pubitemid 44631359)
32. Takeshita M, Chang C-N, Johnson F, Will S, Grollman AP. Oligodeoxynucleotides containing synthetic abasic sites. Model substrates for DNA polymerases and apurinic/apyrimidinic endonucleases. J Biol Chem 1987;262:10171-9.
33. Wilson DM, Takeshita M, Grollman AP, Demple B. Incision activity of human apurinic endonuclease (Ape) at abasic site analogs in DNA. J Biol Chem 1995;270:16002-7.
34. Hill JW, Hazra TK, Izumi T, Mitra S. Stimulation of human 8-oxoguanine-DNA glycosylase by AP-endonuclease: potential coordination of the initial steps in base excision repair. Nucleic Acids Res 2001;29:430-8. (Pubitemid 32060930)
35. Parsons JL, Dianova II, Dianov GL. APE1 is the major 3′- phosphoglycolate activity in human cell extracts. Nucleic Acids Res 2004; 32:3531-6. (Pubitemid 39157703)
36. Parsons JL, Dianova II, Dianov GL. APE1-dependent repair of DNA single-strand breaks containing 3′-end 8-oxoguanine. Nucleic Acids Res 2005;33:2204-9. (Pubitemid 41439888)
37. Gros L, Ishchenko AA, Ide H, Elder RH, Saparbaev MK. The major human AP endonuclease (Ape1) is involved in the nucleotide incision repair pathway. Nucleic Acids Res 2004;32:73-81. (Pubitemid 38228606)
38. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009;11:601- 20.
39. Luo M, He H, Kelley MR, Georgiadis MM. Redox regulation of DNA repair: implications for human health and cancer therapeutic development. Antioxid Redox Signal 2010;12:1247-69.
40. Tell G, Fantini D, Quadrifoglio F. Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment. Cell Mol Life Sci 2010;67:3589-608.
41. Wilson DM3rd, Simeonov A. Small molecule inhibitors of DNA repair nuclease activities of APE1. Cell Mol Life Sci. 2010;67: 3621-31.
42. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418- 29.
43. Vansteenkiste J, Dooms C, Mascaux C, Nackaerts K. Screening and early detection of lung cancer. Ann Oncol 2012;23:x320-7.
44. Nawa T, Nakagawa T, Mizoue T, Kusano S, Chonan T, Hayashihara K, et al. A decrease in lung cancer mortality following the introduction of low-dose chest CT screening in Hitachi, Japan. Lung Cancer 2012; 78:225-8.